Publikationen

U. Bergmann, H. Funatomi, M. Kornmann, H.G. Beger, and M. Korc. Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commun, 1996. 220(3): p. 886-890. view this abstract

K.H. Link, M. Kornmann, G.H. Leder, U. Butzer, J. Pillasch, L. Staib, F. Gansauge, and H.G. Beger. Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial. Clin Cancer Res, 1996. 2(9): p. 1469-1474. view this abstract

T. Ishiwata, U. Bergmann, M. Kornmann, M. Lopez, H.G. Beger, and M. Korc. Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. Pancreas, 1997. 15(4): p. 367-373. view this abstract

M. Kornmann, T. Ishiwata, H.G. Beger, and M. Korc. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene, 1997. 15(12): p. 1417-1424. view this abstract

M. Kornmann, K.H. Link, H.J. Lenz, J. Pillasch, R. Metzger, U. Butzer, G.H. Leder, M. Weindel, F. Safi, K.D. Danenberg, H.G. Beger, and P.V. Danenberg. Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy. Cancer Lett, 1997. 118(1): p. 29-35. view this abstract

T. Ishiwata, M. Kornmann, H.G. Beger, and M. Korc. Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis. Gut, 1998. 43(1): p. 134-139. view this abstract

M. Kornmann, N. Arber, and M. Korc. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest, 1998. 101(2): p. 344-352.<br/> view this abstract

M. Kornmann, H.G. Beger, and M. Korc. Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas, 1998. 17(2): p. 169-175. view this abstract

M. Kornmann, T. Ishiwata, N. Arber, H.G. Beger, and M. Korc. Increased cyclin D1 expression in chronic pancreatitis. Pancreas, 1998. 17(2): p. 158-162. view this abstract

M. Kornmann, T. Ishiwata, J. Itakura, P. Tangvoranuntakul, H.G. Beger, and M. Korc. Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology, 1998. 55(4): p. 363-369. view this abstract

M. Kornmann, H. Maruyama, U. Bergmann, P. Tangvoranuntakul, H.G. Beger, M.F. White, and M. Korc. Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res, 1998. 58(19): p. 4250-4254. view this abstract

K.H. Link, G. Leder, J. Pillasch, U. Butzer, L. Staib, M. Kornmann, U. Bruckner, and H.G. Beger. In vitro concentration response studies and in vitro phase II tests as the experimental basis for regional chemotherapeutic protocols. Semin Surg Oncol, 1998. 14(3): p. 189-201. view this abstract

M. Kornmann, K.D. Danenberg, N. Arber, H.G. Beger, P.V. Danenberg, and M. Korc. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res, 1999. 59(14): p. 3505-3511. view this abstract

M. Kornmann, J. Kleeff, W. Debinski, and M. Korc. Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4. Anticancer Res, 1999. 19(1A): p. 125-131. view this abstract

M. Kornmann, P. Tangvoranuntakul, and M. Korc. TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor. Int J Cancer, 1999. 83(2): p. 247-254. view this abstract

K.H. Link, M. Kornmann, A. Formentini, G. Leder, E. Sunelaitis, M. Schatz, J. Pressmar, and H.G. Beger. Regional chemotherapy of non-resectable liver metastases from colorectal cancer - literature and institutional review. Langenbecks Arch Surg, 1999. 384(4): p. 344-353. view this abstract

K.H. Link, M. Kornmann, G. Leder, A.F. Pillasch, E. Sunelaitis, M. Schatz, J. Pressmar, and H.G. Beger. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. Gan To Kagaku Ryoho, 1999. 26(3): p. 269-281. view this abstract

K.H. Link, G. Leder, A. Formentini, G. Fortnagel, M. Kornmann, M. Schatz, and H.G. Beger. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts. Gan To Kagaku Ryoho, 1999. 26(1): p. 10-40. view this abstract

K.H. Link, J. Pillasch, A. Formentini, E. Sunelaitis, G. Leder, F. Safi, M. Kornmann, and H.G. Beger. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases. Eur J Surg Oncol, 1999. 25(4): p. 381-388. view this abstract

J. Itakura, T. Ishiwata, B. Shen, M. Kornmann, and M. Korc. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer, 2000. 85(1): p. 27-34. view this abstract

J. Kleeff, M. Kornmann, H. Sawhney, and M. Korc. Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells. Int J Cancer, 2000. 86(3): p. 399-407. view this abstract

M. Kornmann, U. Butzer, J. Blatter, H.G. Beger, and K.H. Link. Pre-clinical evaluation of the activity of gemcitabine as a basis for regional chemotherapy of pancreatic and colorectal cancer. Eur J Surg Oncol, 2000. 26(6): p. 583-587. view this abstract

M. Kornmann, H. Fakler, U. Butzer, H.G. Beger, and K.H. Link. Oxaliplatin exerts potent in vitro cytotoxicity in colorectal and pancreatic cancer cell lines and liver metastases. Anticancer Res, 2000. 20(5A): p. 3259-3264. view this abstract

M. Kornmann, T. Ishiwata, J. Kleeff, H.G. Beger, and M. Korc. Fas and Fas-ligand expression in human pancreatic cancer. Ann Surg, 2000. 231(3): p. 368-379. view this abstract

M. Kornmann, T. Ishiwata, H. Maruyama, H.G. Beger, and M. Korc. Coexpression of FAS and FAS-ligand in chronic pancreatitis: correlation with apoptosis. Pancreas, 2000. 20(2): p. 123-128. view this abstract

G.H. Leder, J. Pillasch, M. Kornmann, P.V. Danenberg, and K.H. Link. Theoretical considerations and in vitro concentration response studies with two human colorectal carcinoma cell lines. The rational experimental base for clinical studies in regional chemotherapy. Gan To Kagaku Ryoho, 2000. 27(4): p. 565-577. view this abstract

K.H. Link, M. Kornmann, U. Butzer, G. Leder, E. Sunelaitis, J. Pillasch, D. Salonga, K.D. Danenberg, P.V. Danenberg, and H.G. Beger. Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy. Cancer, 2000. 89(2): p. 288-296. view this abstract

M. Kornmann, M. Lopez, H. Beger, and M. Korc. Expression of the IIIc Variant of FGF Receptor-1 Confers Mitogenic Responsiveness to Heparin and FGF-5 in TAKA-1 Pancreatic Ductal Cells. Int J Gastrointest Cancer, 2001. 29(2): p. 85-92. view this abstract

K.H. Link, L. Staib, M. Kornmann, A. Formentini, M. Schatz, P. Suhr, P. Messer, E. Rottinger, and H.G. Beger. Surgery, radio- and chemotherapy for multimodal treatment of rectal cancer. Swiss Surg, 2001. 7(6): p. 256-274. view this abstract

K.H. Link, E. Sunelaitis, M. Kornmann, M. Schatz, F. Gansauge, G. Leder, A. Formentini, L. Staib, J. Pillasch, and H.G. Beger. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival. Cancer, 2001. 92(11): p. 2746-2753. view this abstract

M. Kornmann, T. Ishiwata, K. Matsuda, M.E. Lopez, K. Fukahi, G. Asano, H.G. Beger, and M. Korc. IIIc isoform of fibroblast growth factor receptor 1 is overexpressed in human pancreatic cancer and enhances tumorigenicity of hamster ductal cells. Gastroenterology, 2002. 123(1): p. 301-313. view this abstract

M. Kornmann and K.H. Link. Conversion of locally inoperable primary rectal cancer with multiple liver metastases to an option for cure after local down-staging and hepatic arterial infusion chemotherapy. Langenbecks Arch Surg, 2002. 387(2): p. 90-93. view this abstract

M. Kornmann, K.H. Link, I. Galuba, K. Ott, W. Schwabe, P. Hausler, P. Scholz, J. Strater, S. Polat, B. Leibl, E. Kettner, C. Schlichting, W. Baumann, H. Schramm, U. Hecker, K. Ridwelski, J.H. Vogt, K.U. Zerbian, F. Schutze, E.D. Kreuser, D. Behnke, and H.G. Beger. Association of time to recurrence with thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression in stage II and III colorectal cancer. J Gastrointest Surg, 2002. 6(3): p. 331-337. view this abstract

J. Strater, H. Walczak, T. Pukrop, L. Von Muller, C. Hasel, M. Kornmann, T. Mertens, and P. Moller. TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections. Gastroenterology, 2002. 122(3): p. 659-666. view this abstract

I. Guthoff, E. Lotspeich, C. Fester, I. Wallin, M. Schatz, H. Ehrsson, and M. Kornmann. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. Anticancer Res, 2003. 23(6D): p. 5203-5208. view this abstract

M. Kornmann, H.G. Beger, and K.H. Link. Chemosensitivity testing and test-directed chemotherapy in human pancreatic cancer. Recent Results Cancer Res, 2003. 161: p. 180-195. view this abstract

M. Kornmann, W. Schwabe, S. Sander, M. Kron, J. Strater, S. Polat, E. Kettner, H.F. Weiser, W. Baumann, H. Schramm, P. Hausler, K. Ott, D. Behnke, L. Staib, H.G. Beger, and K.H. Link. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clin Cancer Res, 2003. 9(11): p. 4116-4124. view this abstract

A. Formentini, D. Henne-Bruns, and M. Kornmann. Thymidylate synthase expression and prognosis of patients with gastrointestinal cancers receiving adjuvant chemotherapy: a review. Langenbecks Arch Surg, 2004. 389(5): p. 405-413. view this abstract

A. Hillenbrand, A. Formentini, L. Staib, S. Sander, D. Salonga, K. Danenberg, P. Danenberg, and M. Kornmann. A longterm follow-up study of thymidylate synthase as a predictor for survival of patients with liver tumours receiving hepatic arterial infusion chemotherapy. Eur J Surg Oncol, 2004. 30(4): p. 407-413. view this abstract

C. Hofmann, K. Buttenschoen, J. Straeter, D. Henne-Bruns, and M. Kornmann. Pre-clinical evaluation of the activity of irinotecan as a basis for regional chemotherapy. Anticancer Res, 2005. 25(2A): p. 795-804. view this abstract

K.H. Link, M. Kornmann, L. Staib, M. Redenbacher, M. Kron, and H.G. Beger. Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha. Ann Surg, 2005. 242(2): p. 178-187. view this abstract

K.H. Link, T.A. Sagban, M. Morschel, K. Tischbirek, M. Holtappels, V. Apell, K. Zayed, M. Kornmann, and L. Staib. Colon cancer: survival after curative surgery. Langenbecks Arch Surg, 2005. 390(2): p. 83-93. view this abstract

O. Prokopchuk, Y. Liu, D. Henne-Bruns, and M. Kornmann. Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. Br J Cancer, 2005. 92(5): p. 921-928. view this abstract

Z.B. Liu, Y.M. Yang, Q.L. Qiao, Y.L. Wan, M. Kornmann, and Y.T. Huang. [The role of human fibroblast growth factor receptor 1-IIIb isoform in proliferation of pancreatic ductal cells and its effects to mitogen-activated protein kinase]. Zhonghua Yi Xue Za Zhi, 2006. 86(40): p. 2812-2816. view this abstract

Y. Xi, A. Formentini, M. Chien, D.B. Weir, J.J. Russo, J. Ju, and M. Kornmann. Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights, 2006. 2: p. 113-121. view this abstract

A. Formentini, S. Sander, S. Denzer, J. Straeter, D. Henne-Bruns, and M. Kornmann. Thymidylate synthase expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker? Int J Colorectal Dis, 2007. 22(1): p. 49-55. view this abstract

Z. Liu, T. Ishiwata, S. Zhou, S. Maier, D. Henne-Bruns, M. Korc, M. Bachem, and M. Kornmann. Human fibroblast growth factor receptor 1-IIIb is a functional fibroblast growth factor receptor expressed in the pancreas and involved in proliferation and movement of pancreatic ductal cells. Pancreas, 2007. 35(2): p. 147-157. view this abstract

Z. Liu, N. Neiss, S. Zhou, D. Henne-Bruns, M. Korc, M. Bachem, and M. Kornmann. Identification of a fibroblast growth factor receptor 1 splice variant that inhibits pancreatic cancer cell growth. Cancer Res, 2007. 67(6): p. 2712-2719. view this abstract

K. Buttenschoen, M. Kornmann, D. Berger, G. Leder, H.G. Beger, and C. Vasilescu. Endotoxemia and endotoxin tolerance in patients with ARDS. Langenbecks Arch Surg, 2008. 393(4): p. 473-478. view this abstract

K. Buttenschoen, M.E. Schneider, K. Utz, M. Kornmann, H.G. Beger, and D. Carli Buttenschoen. Effect of major abdominal surgery on endotoxin release and expression of Toll-like receptors 2/4. Langenbecks Arch Surg, 2008. view this abstract

G. Chen, J. Wang, Z. Liu, and M. Kornmann. Exon III splicing of fibroblast growth factor receptor 1 is modulated by growth factors and cyclin D1. Pancreas, 2008. 37(2): p. 159-164. view this abstract

M. Kornmann, A. Formentini, C. Ette, D. Henne-Bruns, M. Kron, S. Sander, W. Baumann, E.D. Kreuser, L. Staib, and K.H. Link. Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment. Eur J Surg Oncol, 2008. view this abstract

M. Kornmann and D. Henne-Bruns. [Quality for the data basis of evidence-based medicine: rectal cancer and preoperative 5 x 5 irradiation]. Zentralbl Chir, 2008. 133(1): p. 20-24. view this abstract

M. Kornmann, F. Porzsolt, and D. Henne-Bruns. [Lay assessment of health care services using therapy for rectal cancer as an example]. Zentralbl Chir, 2008. 133(2): p. 148-155. view this abstract

Y. Xi, A. Formentini, G. Nakajima, M. Kornmann, and J. Ju. Validation of biomarkers associated with 5-fluorouracil and thymidylate synthase in colorectal cancer. Oncol Rep, 2008. 19(1): p. 257-262. view this abstract

Neuer Standort
Oberer Eselsberg

Die chirurgischen Kliniken, Radiologie, Anästhesiologie und Dermatologie ziehen um [mehr]

Flyer zum Ausdrucken